PRESS RELEASE: Admaius Capital Partners Announces Successful Exit From Parkville Pharmaceuticals
4 Articles
4 Articles
Adenia Partners Makes First Majority Investment in Egypt with Acquisition of Parkville Pharmaceuticals
CAIRO--(BUSINESS WIRE)--Adenia Partners (“Adenia”), a leading private equity firm focused on growth opportunities in Africa, has signed definitive agreements to acquire a majority stake in Parkville Pharmaceuticals from Admaius Capital Partners (“Admaius”), a prominent Africa-focused private equity firm, alongside Dr. Sherif Bassiouny, Chairman of Parkville, and Dr. Mahmoud Farrag, CEO of Parkville. Parkville is a [...] The post Adenia Partners …
Adenia Partners to acquire majority stake in Egypt’s Parkville from Admaius - Dailynewsegypt
Private equity firm Adenia Partners has signed definitive agreements to acquire a majority stake in Egypt’s Parkville Pharmaceuticals from Admaius Capital Partners and the company’s founders, the parties announced on Monday. The transaction, which remains subject to customary closing conditions and regulatory approvals, marks the first exit for Admaius Capital Partners’ current fund. Financial terms
PRESS RELEASE: Admaius Capital Partners announces successful exit from Parkville Pharmaceuticals
25 January 2026 Cairo, Egypt – Admaius Capital Partners (“Admaius”), a market-leading pan-African private equity firm, along with Dr. Sherif Bassiouny, Chairman of Parkville Pharmaceuticals (“Parkville”), and Dr. Mahmoud Farrag, CEO of Parkville, has signed definitive agreements to sell a majority stake in Parkville to Adenia Partners (“Adenia”). The transaction is subject to customary closing conditions and regulatory approvals. Financial terms…
In cooperation with Dr. Sharif Bassiouni, Chairman of the Board of Directors of Parkville Pharmaceuticals, and Dr. Mahmoud Faraj, CEO of the Company, the leading direct investment in Africa, announced that final agreements had been signed for the sale of a majority interest in Parkville to Adinia Partners.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium

